| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 23, 2022 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 136 | $42.30 | $5,752.92 | - | +34.1% | +46.5% | |
| Dec 23, 2022 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 1,660 | $42.30 | $70,218.83 | -2.0% | +34.1% | +46.5% | |
| Dec 23, 2022 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 429 | $42.30 | $18,146.96 | -0.5% | +34.1% | +46.5% | |
| Dec 23, 2022 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 476 | $42.30 | $20,134.66 | -0.3% | +34.1% | +46.5% | |
| Dec 22, 2022 | IMDX Insight Molecular Diagnostics Inc. | Kingsley Alfred D | Director | Buy | 25,000 | $0.29 | $7,125.00 | +6.0% | -16.8% | -56.0% | |
| Dec 22, 2022 | RVTY Revvity, Inc. | Vohra Tajinder S75 | Please See Remarks | Sell | 3,325 | $141.29 | $469,773.94 | -3.0% | -11.5% | -23.8% | |
| Dec 21, 2022 | RVTY Revvity, Inc. | Singh Prahlad R.53 | Please See Remarks | Sell | 14,187 | $140.52 | $1,993,553.89 | -12.8% | -11.7% | -25.6% | |
| Dec 20, 2022 | PSNL Personalis, Inc. | Chen Richard70 | Chief Medical Officer | Sell | 1,750 | $1.92 | $3,360.00 | -1.3% | +50.6% | -18.0% | |
| Dec 20, 2022 | RVTY Revvity, Inc. | Goldberg Joel S58 | Please See Remarks | Sell | 35,907 | $138.86 | $4,985,948.43 | -23.0% | -11.3% | -25.4% | |
| Dec 20, 2022 | PRPO Precipio, Inc. | Sandberg Richard A74 | Director | Buy | 20,000 | $0.55 | $11,050.00 | +2,364% | +20.7% | -34.6% | |
| Dec 20, 2022 | PSNL Personalis, Inc. | Tachibana Aaron68 | Chief Financial Officer | Sell | 3,843 | $1.92 | $7,378.56 | -1.8% | +50.6% | -18.0% | |
| Dec 20, 2022 | RVTY Revvity, Inc. | Vohra Tajinder S75 | Please See Remarks | Sell | 3,325 | $138.70 | $461,166.35 | -3.6% | -11.3% | -25.4% | |
| Dec 19, 2022 | RDNT Radnet, Inc. | Hames Norman R56 | Pres And Coo-west Operations | Sell | 5,000 | $19.45 | $97,225.00 | -1.8% | +23.1% | +84.5% | |
| Dec 19, 2022 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 8,958 | $23.07 | $206,677.85 | -0.7% | -7.0% | -8.1% | |
| Dec 19, 2022 | RDNT Radnet, Inc. | Gordon Christine Nayoma | - | Sell | 3,000 | $19.57 | $58,695.00 | -24.0% | +23.1% | +84.5% | |
| Dec 16, 2022 | PMDI Psychemedics Corp | Schaffer Michael I | VP Of Laboratory Operations | Buy | 100 | $4.95 | $495.00 | +0.3% | - | - | |
| Dec 16, 2022 | BDSX Biodesix Inc | Schuler Jack W45 | Director, 10% Owner | Buy | 10,000 | $1.70 | $17,000.00 | - | +8.2% | -7.6% | |
| Dec 15, 2022 | PSNL Personalis, Inc. | Moore Stephen Michael52 | General Counsel | Sell | 1,930 | $2.50 | $4,825.00 | -2.1% | +20.0% | -34.3% | |
| Dec 15, 2022 | PSNL Personalis, Inc. | Chen Richard70 | Chief Medical Officer | Sell | 7,177 | $2.50 | $17,942.50 | -5.0% | +20.0% | -34.3% | |
| Dec 15, 2022 | RVTY Revvity, Inc. | Okun Andrew76 | Please See Remarks | Sell | 8,150 | $140.97 | $1,148,913.45 | -33.8% | -13.1% | -28.3% | |
| Dec 15, 2022 | PSNL Personalis, Inc. | Tachibana Aaron68 | Chief Financial Officer | Sell | 7,177 | $2.50 | $17,942.50 | -3.3% | +20.0% | -34.3% | |
| Dec 15, 2022 | TMO Thermo Fisher Scientific Inc. | Spar Debora L54 | Director | Sell | 200 | $561.39 | $112,278.00 | -17.0% | -2.0% | -6.5% | |
| Dec 15, 2022 | BDSX Biodesix Inc | Schuler Jack W45 | Director, 10% Owner | Buy | 20,000 | $1.65 | $32,952.00 | - | +11.8% | -7.1% | |
| Dec 14, 2022 | VCYT Veracyte, Inc. | Jones Evan/ Fa70 | Director | Sell | 600 | $30.13 | $18,080.16 | -1.2% | -20.8% | -2.3% | |
| Dec 14, 2022 | A Agilent Technologies, Inc. | Ancher-Jensen Henrik49 | Sr Vice President | Sell | 29,500 | $155.78 | $4,595,510.00 | -29.4% | -10.6% | -10.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.